Helps to reduce scars and depression
Post hoc subgroup analysis of composite cardiovascular outcome and new-onset dialysis was further conducted
Min Z, Yang L, Hu Y, Huang R
Clinical trials of GLP-1 patches have consistently shown lower and more variable absorption compared to subcutaneous injections, meaning patients experience less predictable appetite suppression and metabolic effects
Improvements in glycaemic control, blood pressure, and lipid profiles have been documented, potentially reducing cardiovascular risk
Combined Approaches (Neelakantan et al., 2022): NNMT inhibition with reduced-calorie diet produced dramatic adiposity reduction in DIO mice, normalizing metabolic parameters and establishing a distinct gut microbiome